In a scenario where exogenous angiotensin II is administered with a drug that blocks angiotensin II formation, what best describes the drug’s action?

Prepare for the NBME Form 16 with our comprehensive quiz. Tackle multiple choice questions with insights and explanations. Enhance your confidence and accuracy for the exam!

Multiple Choice

In a scenario where exogenous angiotensin II is administered with a drug that blocks angiotensin II formation, what best describes the drug’s action?

Explanation:
Partial agonists activate receptors but produce a submaximal response compared with a full agonist. In this scenario, angiotensin II is the full agonist at AT1 receptors, so when a drug that blocks angiotensin II formation is present, any exogenous Ang II can still activate the receptors but to a lesser extent if the blocker acts as a partial agonist. The drug will occupy some receptors and provide only partial signaling, thereby dampening the overall Ang II–mediated effect. It’s not a pure antagonist because it still produces some receptor activity, and it’s not an irreversible ACE inhibitor since the action is at the receptor level, not the enzyme.

Partial agonists activate receptors but produce a submaximal response compared with a full agonist. In this scenario, angiotensin II is the full agonist at AT1 receptors, so when a drug that blocks angiotensin II formation is present, any exogenous Ang II can still activate the receptors but to a lesser extent if the blocker acts as a partial agonist. The drug will occupy some receptors and provide only partial signaling, thereby dampening the overall Ang II–mediated effect. It’s not a pure antagonist because it still produces some receptor activity, and it’s not an irreversible ACE inhibitor since the action is at the receptor level, not the enzyme.

Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy